Totalfinaelf S.A. (TOT) 48.51 $TOT SunPower Awarded 76

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Totalfinaelf S.A. (TOT) 48.51 $TOT

SunPower Awarded 76 Percent of France's ZNI Tender
PR Newswire - Thu Jul 07, 1:00AM CDT
SunPower Corp. (Nasdaq: SPWR) announced today that it was selected to provide 39.1 megawatts of solar photovoltaic technology under the French government's tender for supplying the country's ZNI (non-interconnected zones) with renewable energy and storage. SunPower secured 27 out of the total of 33 awards, or 76 percent, under the tender program. As part of its award, SunPower developed and will design and build five solar power installations in Corsica and the French West Indies, which will include battery storage technology.
TOT: 48.51 (-0.11), SPWR: 14.85 (-0.38)

After Yesterday's Rally of 1.12% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Jul 01, 1:26PM CDT
Total (NYSE:TOT) traded in a range yesterday that spanned from a low of $48.48 to a high of $48.91. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $48.46 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TOT: 48.51 (-0.11)

Total Set to Possibly Pullback After Yesterday's Rally of 1.12%
Comtex SmarTrend(R) - Fri Jul 01, 1:24PM CDT
Total (NYSE:TOT) traded in a range yesterday that spanned from a low of $48.48 to a high of $48.91. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $48.46 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TOT: 48.51 (-0.11)

Downgrade Alert for Total (TOT)
Comtex SmarTrend(R) - Fri Jul 01, 3:21AM CDT
Total (NYSE:TOT) was downgraded from Overweight to Equal Weight at Morgan Stanley today. The stock closed yesterday at $48.10 on volume of 3.0 million shares, above average daily volume of 2.1 million. Potential upside of 10.9% exists for Total, based on a current level of $48.10 and analysts' average consensus price target of $53.32. The stock should discover initial support at its 50-day moving average (MA) of $47.02 and subsequent support at its 200-day MA of $46.60.
TOT: 48.51 (-0.11)

TOTAL Gets 30% Right in Qatar's Offshore Al-Shaheen Field
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 9:11AM CDT
TOTAL S.A. (TOT) won a competitive bid to acquire a 30% interest in Qatar's offshore Al-Shaheen oil field.
RDS.A: 55.53 (-0.28), TOT: 48.51 (-0.11), BP: 36.56 (-0.35), SPWR: 14.85 (-0.38)

Technip's 10 Top-Valued Projects Show Strong Role in Onshore, Offshore, LNG Markets, an Industrial Info News Alert
Marketwired - Tue Jun 28, 6:30AM CDT
SUGAR LAND, TX--(Marketwired - Jun 28, 2016) - Researched by Industrial Info Resources (Sugar Land, Texas) -- Technip S.A. (Paris, France), a leading engineering, project management and construction company for the global energy market, is doing strong business amid the downturn in oil prices. The company reported a total backlog of roughly 15 billion euros at the end of the previous quarter -- down from last year, but spread across onshore and offshore projects, as well as technology, consulting and equipment work. Industrial Info's project database is tracking 273 projects, worth $145.35 billion, that involve Technip in some capacity; about 93% of the total investment value is attributed to just three industries: Oil & Gas Production, Petroleum Refining, and Chemical Processing.
ETP: 38.17 (-0.51), SSL: 27.17 (-0.59), TOT: 48.51 (-0.11), STO: 17.47 (-0.19)

Brexit: How Does It Affect Energy? Here Are a Few Answers
Nilanjan Choudhury - Zacks Investment Research - Fri Jun 24, 12:45PM CDT
Brexit jitters hit oil, but investors need not panic.
RDS.A: 55.53 (-0.28), TOT: 48.51 (-0.11), APA: 56.54 (-1.00), BP: 36.56 (-0.35), STO: 17.47 (-0.19)

ABB Prospects Bright despite Macro Woes: Should You Hold?
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 7:15AM CDT
Power and automation technology provider ABB Ltd. (ABB) has emerged as the dark horse in the equipment and technology space, as per Industrial Info Resources -- a leading provider of global market intelligence.
ABB: 19.63 (+0.10), TOT: 48.51 (-0.11), FLOW: 27.33 (+0.08), STO: 17.47 (-0.19)

SmarTrend Watching for Potential Pullback in Shares of Total After 1.02% Gain
Comtex SmarTrend(R) - Fri Jun 17, 2:22PM CDT
Total (NYSE:TOT) traded in a range yesterday that spanned from a low of $46.31 to a high of $46.88. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $46.18 on volume of 987,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TOT: 48.51 (-0.11)

The Zacks Analyst Blog Highlights: Royal Dutch Shell, BP, Eni SpA, Statoil and TOTAL
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 8:30AM CDT
The Zacks Analyst Blog Highlights: Royal Dutch Shell, BP, Eni SpA, Statoil and TOTAL
E: 32.69 (-0.18), RDS.A: 55.53 (-0.28), TOT: 48.51 (-0.11), BP: 36.56 (-0.35), STO: 17.47 (-0.19)

Is Iran the World's Next Big Oil Story?
Nilanjan Choudhury - Zacks Investment Research - Wed Jun 15, 11:47AM CDT
Iran is set to emerge as the next big destination for major western oil groups.
E: 32.69 (-0.18), RDS.A: 55.53 (-0.28), TOT: 48.51 (-0.11), BP: 36.56 (-0.35), STO: 17.47 (-0.19)

Shell, Gazprom to Enter into Agreement on Baltic LNG Project
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 9:14AM CDT
According to a report recently published by Reuters, integrated energy major, Royal Dutch Shell plc (RDS.A) and Russian gas giant Gazprom are expected to enter into an agreement on a planned Baltic liquefied natural gas (LNG) project.
RDS.A: 55.53 (-0.28), TOT: 48.51 (-0.11), PBFX: 21.78 (-0.09), PTR: 68.79 (-1.62)

Total Set to Possibly Rebound After Yesterday's Selloff of 1.10%
Comtex SmarTrend(R) - Mon Jun 13, 4:12PM CDT
Total (NYSE:TOT) traded in a range yesterday that spanned from a low of $46.55 to a high of $47.32. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $46.91 on volume of 753,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TOT: 48.51 (-0.11)

TOTAL French Refineries Resuming Work Post Labor Strike
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 9:37AM CDT
TOTAL's (TOT) refineries in France are gradually resuming normal operations after being hit by labor strikes.
BAK: 11.31 (+0.06), TOT: 48.51 (-0.11), XOM: 94.88 (-0.07), PTR: 68.79 (-1.62)

Shell to Restart Purchase of Crude from Iran After Total
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 8:06AM CDT
Europe's largest energy producer Royal Dutch Shell plc (RDS.A) has decided to restart buying Iranian crude is now grabbing attention
BAK: 11.31 (+0.06), RDS.A: 55.53 (-0.28), SSL: 27.17 (-0.59), TOT: 48.51 (-0.11), PTR: 68.79 (-1.62)

Crude Oil Hits $50: Energy Stock Winners Year to Date
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:48AM CDT
A new ray of hope can be seen in the energy space with the crude barrier for both Brent and WTI breaching the $50 per barrel.
RDS.A: 55.53 (-0.28), TOT: 48.51 (-0.11), BBG: 6.10 (-0.23), XOM: 94.88 (-0.07), BP: 36.56 (-0.35), DNR: 3.35 (-0.32), DWSN: 7.61 (-0.91), SWN: 13.96 (-0.24), BHI: 45.26 (-0.56)

Look for Shares of Total to Potentially Pullback after Yesterday's 1.39% Rise
Comtex SmarTrend(R) - Mon Jun 06, 2:55PM CDT
Total (NYSE:TOT) traded in a range yesterday that spanned from a low of $48.10 to a high of $48.59. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $47.74 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TOT: 48.51 (-0.11)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 8

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 7

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Shareholder Investigations in Various Companies

Updated Category News Views 261

Overview of Current Shareholder Investigations Brodsky & Smith, a well-known litigation law firm, is actively reminding shareholders about various ongoing investigations involving Sealed Air Corporation, Movano Inc., Gulf Island Inc., and Denny's Corporation. If you are a shareholder interested in obtaining more information regarding these investigations, you can reach...

Continue Reading
Nykredit Announces Voluntary Tender Offer for Spar Nord Bank

Updated Category News Views 147

Nykredit Announces a Voluntary Public Tender Offer for Spar Nord Bank Nykredit Realkredit A/S, a prominent player in the Danish financial landscape, has publicly unveiled its plans for a voluntary tender offer directed at Spar Nord Bank A/S. This anticipated offer, which signals Nykredit's strategic expansion ambitions, seeks to acquire all available shares in Spar Nord...

Continue Reading
Big 5 Sporting Goods Embarks on New Growth Journey After Merger

Updated Category News Views 292

Big 5 Sporting Goods Corporation Announces Merger Completion Big 5 Sporting Goods Corporation (Nasdaq: BGFV), a well-established name in the sporting goods industry, has successfully completed its merger with a partnership composed of Worldwide Golf and Capitol Hill Group. This new chapter for Big 5 is expected to propel the company towards greater heights. Merger Details...

Continue Reading
UCB's BIMZELX® Data: A Game Changer for Arthritis Care

Updated Category News Views 132

UCB's Innovative Efforts in Arthritis Treatment UCB is making significant strides in the field of rheumatology, particularly with the release of new data regarding BIMZELX® (bimekizumab-bkzx) presented at the ACR Convergence 2024. This marks the first time the company has shared data specifically relating to psoriatic arthritis (PsA), non-radiographic axial...

Continue Reading
Mega Matrix Launches Captivating Urban Romance on FlexTV

Updated Category News Views 614

Engaging Romance Premieres on FlexTV Mega Matrix Inc. (NYSE American: MPU) has unveiled a captivating romantic miniseries titled A flash Marriage With The Billionaire Tycoon, streaming on its renowned short series platform, FlexTV. This adventurous drama dives into themes of love, responsibility, and the quest for personal redemption, showcasing the complicated lives of...

Continue Reading